Article
Thiosemicarbazones Functioning as Zinc Metallochaperones to Reactivate Mutant p53.
Molecular pharmacology - 1 Jun 2017
Yu Xin, Blanden Adam, Tsang Ashley T, Zaman Saif, Liu Yue, Gilleran John, Bencivenga Anthony F, Kimball S David, Loh Stewart N, Carpizo Darren R
Abstract excerpt
Small-molecule restoration of wild-type structure and function to mutant p53 (so-called mutant reactivation) is a highly sought-after goal in cancer drug development. We previously discovered that small-molecule zinc chelators called zinc metallochaperones (ZMCs) reactivate mutant p53 by restoring zinc binding to zinc-deficient p53 mutants. The lead compound identified from the NCI-60 human tumor cell lines...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
